Kenneth McGrath - OraSure Technologies Chief Officer
| OSUR Stock | USD 3.91 0.17 4.17% |
Insider
Kenneth McGrath is Chief Officer of OraSure Technologies
| Age | 52 |
| Address | 220 East First Street, Bethlehem, PA, United States, 18015 |
| Phone | 610 882 1820 |
| Web | https://www.orasure.com |
Kenneth McGrath Latest Insider Activity
Tracking and analyzing the buying and selling activities of Kenneth McGrath against OraSure Technologies stock is an integral part of due diligence when investing in OraSure Technologies. Kenneth McGrath insider activity provides valuable insight into whether OraSure Technologies is net buyers or sellers over its current business cycle. Note, OraSure Technologies insiders must abide by specific rules, including filing SEC forms every time they buy or sell OraSure Technologies'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Kenneth McGrath over a month ago Disposition of 12524 shares by Kenneth McGrath of OraSure Technologies at 6.49 subject to Rule 16b-3 |
OraSure Technologies Management Efficiency
As of 12/14/2024, Return On Tangible Assets is likely to grow to 0.13. Also, Return On Capital Employed is likely to grow to 0.13. At this time, OraSure Technologies' Return On Assets are relatively stable compared to the past year. OraSure Technologies' management efficiency ratios could be used to measure how well OraSure Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Eric Conley | Envista Holdings Corp | N/A | |
| A Bender | The Cooper Companies, | 79 | |
| Elisabeth Hellmann | Hologic | 55 | |
| Teresa Madden | The Cooper Companies, | 65 | |
| Isabel MareySemper | AptarGroup | 53 | |
| Richard Rosenzweig | AngioDynamics | 57 | |
| Curt Bludworth | Envista Holdings Corp | 53 | |
| Carla Burigatto | Haemonetics | N/A | |
| Kimberly Chainey | AptarGroup | 48 | |
| John Knorpp | Merit Medical Systems | N/A | |
| Jason Treft | Merit Medical Systems | N/A | |
| Clifford Hoyt | Akoya Biosciences | N/A | |
| Gayle Sheppard | Envista Holdings Corp | 66 | |
| Heidi Tlili | AptarGroup | 49 | |
| Francis Tan | Haemonetics | N/A | |
| CCEP CCEP | AtriCure | 52 | |
| Gerard III | The Cooper Companies, | 59 | |
| CPA Parra | Merit Medical Systems | 46 | |
| Kevin Thornal | Hologic | 50 | |
| Mark Drury | The Cooper Companies, | 45 | |
| Tom Adams | Repro Med Systems | N/A | |
Management Performance
| Return On Equity | 0.0274 | ||||
| Return On Asset | 0.0071 |
OraSure Technologies Leadership Team
Elected by the shareholders, the OraSure Technologies' board of directors comprises two types of representatives: OraSure Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OraSure. The board's role is to monitor OraSure Technologies' management team and ensure that shareholders' interests are well served. OraSure Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OraSure Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carrie Manner, CEO President | ||
| CFA CFA, Strategy Devel | ||
| Jason Plagman, Vice Relations | ||
| Amy Steigerwalt, Senior Resources | ||
| Michele Miller, Vice President - Finance, Controller | ||
| Stefano Taucer, General Secretary | ||
| David CFA, Strategy Development | ||
| Rafal Iwasiow, Innovation Science | ||
| Michele Anthony, Chief VP | ||
| Kathleen Weber, Executive Vice President Business Unit Leader, Molecular Solutions at DNAG | ||
| Scott Gleason, Sr Communications | ||
| Zachary Wert, Senior Operations | ||
| Trace Custer, Senior Regulatory | ||
| Kenneth McGrath, Chief Officer |
OraSure Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OraSure Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0274 | ||||
| Return On Asset | 0.0071 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 24.2 M | ||||
| Shares Outstanding | 74.59 M | ||||
| Shares Owned By Insiders | 3.04 % | ||||
| Shares Owned By Institutions | 91.58 % | ||||
| Number Of Shares Shorted | 1.29 M | ||||
| Price To Earning | 147.43 X |
Pair Trading with OraSure Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OraSure Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OraSure Technologies will appreciate offsetting losses from the drop in the long position's value.Moving against OraSure Stock
| 0.73 | DXCM | DexCom Inc | PairCorr |
| 0.69 | VREX | Varex Imaging Corp | PairCorr |
| 0.67 | EW | Edwards Lifesciences Corp | PairCorr |
| 0.57 | GH | Guardant Health | PairCorr |
| 0.57 | OM | Outset Medical | PairCorr |
The ability to find closely correlated positions to OraSure Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OraSure Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OraSure Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OraSure Technologies to buy it.
The correlation of OraSure Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OraSure Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OraSure Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OraSure Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OraSure Stock Analysis
When running OraSure Technologies' price analysis, check to measure OraSure Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OraSure Technologies is operating at the current time. Most of OraSure Technologies' value examination focuses on studying past and present price action to predict the probability of OraSure Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OraSure Technologies' price. Additionally, you may evaluate how the addition of OraSure Technologies to your portfolios can decrease your overall portfolio volatility.